These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule. Weeks BS, Nomizu M, Otaka A, Weston CA, Okusu A, Tamamura H, Yamamoto N, Fujii N. Biochem Biophys Res Commun; 1995 Oct 13; 215(2):626-31. PubMed ID: 7488001 [Abstract] [Full Text] [Related]
3. Interaction of an anti-HIV peptide, T22, with gp120 and CD4. Tamamura H, Otaka A, Murakami T, Ishihara T, Ibuka T, Waki M, Matsumoto A, Yamamoto N, Fujii N. Biochem Biophys Res Commun; 1996 Feb 15; 219(2):555-9. PubMed ID: 8605026 [Abstract] [Full Text] [Related]
4. Analysis of the interaction of an anti-HIV peptide, T22 ([Tyr5, 12, Lys7]-polyphemusin II), with gp120 and CD4 by surface plasmon resonance. Tamamura H, Ishihara T, Otaka A, Murakami T, Ibuka T, Waki M, Matsumoto A, Yamamoto N, Fujii N. Biochim Biophys Acta; 1996 Nov 14; 1298(1):37-44. PubMed ID: 8948487 [Abstract] [Full Text] [Related]
11. A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance. Tamamura H, Kuroda M, Masuda M, Otaka A, Funakoshi S, Nakashima H, Yamamoto N, Waki M, Matsumoto A, Lancelin JM. Biochim Biophys Acta; 1993 May 13; 1163(2):209-16. PubMed ID: 8490053 [Abstract] [Full Text] [Related]
12. Structure-activity relationships of an anti-HIV peptide, T22. Tamamura H, Murakami T, Masuda M, Otaka A, Takada W, Ibuka T, Nakashima H, Waki M, Matsumoto A, Yamamoto N. Biochem Biophys Res Commun; 1994 Dec 30; 205(3):1729-35. PubMed ID: 7811258 [Abstract] [Full Text] [Related]
13. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. Murakami T, Nakajima T, Koyanagi Y, Tachibana K, Fujii N, Tamamura H, Yoshida N, Waki M, Matsumoto A, Yoshie O, Kishimoto T, Yamamoto N, Nagasawa T. J Exp Med; 1997 Oct 20; 186(8):1389-93. PubMed ID: 9334379 [Abstract] [Full Text] [Related]
14. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C. Davies AH, Grand RJ, Evans FJ, Rickinson AB. J Virol; 1991 Dec 20; 65(12):6838-44. PubMed ID: 1658377 [Abstract] [Full Text] [Related]
15. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4. Xu Y, Tamamura H, Arakaki R, Nakashima H, Zhang X, Fujii N, Uchiyama T, Hattori T. AIDS Res Hum Retroviruses; 1999 Mar 20; 15(5):419-27. PubMed ID: 10195751 [Abstract] [Full Text] [Related]
16. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion. Nakashima H, Masuda M, Murakami T, Koyanagi Y, Matsumoto A, Fujii N, Yamamoto N. Antimicrob Agents Chemother; 1992 Jun 20; 36(6):1249-55. PubMed ID: 1384424 [Abstract] [Full Text] [Related]